Trial | NCT00215371  Report issue

Title

Study in Patients With Asthma

  • Phase

    Phase 2

  • Lead Sponsor

    Dey

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    formoterol ...

  • Study Participants

    32
The purpose of this study is to determine which dose of the investigational drug is safest and most effective compared to the control group.
Study Started
Jul 31
2002
Primary Completion
Oct 31
2002
Study Completion
Nov 30
2005
Last Update
Nov 11
2010
Estimate

Drug Formoterol Fumarate

Criteria 

Inclusion Criteria:

Require the regular use of an inhaled beta-2-selective adrenergic agent.
No clinically significant abnormalities on the medical history, physical examination, and clinical laboratory tests.

Exclusion Criteria:

Active acute or chronic disorders of the respiratory system within one month prior to screening.
Smoking history within the past 12 months or greater than a lifetime 10 pack-year smoking history.
Debilitating systemic and/or life-threatening diseases.
No Results Posted